Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck/Pfizer’s Bavencio flunks second ovarian cancer trial

pharmaphorumDecember 25, 2018

Tag: Merck , Pfizer , BAVENCIO , ovarian cancer trial

PharmaSources Customer Service